Organon (NYSE: OGN) Unveils Latest Research Results at ISPOR 2026

May 19, 2026

Key Developments Organon (NYSE: OGN), a global healthcare company, announced it will share new research findings at the upcoming ISPOR 2026 conference. The research encompasses multiple therapeutic areas including women’s health, biosimilars, dermatology, and neuroscience. ISPOR 2026, a leading global congress focused on health economics and outcomes research, will be held in Philadelphia from May 17 to 20, 2026. Organon has eight research abstracts accepted for presentation at the conference….

Read More >>